Vesalio

We're excited to share the highly positive results from our NeVa CLEAR Study,* presented recently at the ESMINT annual meeting in Marseille, France, where we also celebrated the fifth anniversary of NeVa’s international commercialization. "The prospective CLEAR Study confirms the value and differentiation of the NeVa device compared to other stent retrievers for achieving rapid and effective revascularization," said Prof. Dr. Serdar Geyik, who presented the results at the ESMINT meeting on behalf of the CLEAR principal investigators. We're proud of this milestone. Click here to access the full press release: https://lnkd.in/gYbhS3-Z *The CLEAR Study, a prospective, multicenter, open-label, single-arm, FDA-regulated IDE trial, evaluated the safety and effectiveness of our #NeVa thrombectomy device in treating acute ischemic #stroke caused by large vessel occlusions (#LVO). NeVa is CE-approved and currently not available in the U.S. #NeVaFirstPass #DoTheDropZone #neurointervention #AIS #ESMINT2023 Diane Demet Tangun, Prof. Dr. Serdar Geyik, Nav Woodlands, Jennifer Geluso, Jessica Koradin, William von Brendel, MBA, MIM, Irene Haslinger, Hans-Juergen Bruns

#DoTheDropZone in Kassel! Vesalio is at #NEURORAD2024 and hopes to see you there! Please stop by our booth or contact Jessica Koradin, Hans-Juergen Bruns, Andreas Scheiner, Marco Hofmann, Diane Demet Tangun to connect! Stop by to hear the latest news on:? ?? #NeVa, for achieving impressive #FirstPassSuccess on ALL clot types ?? #NeVaNET, the world's first and only stent retriever equipped with clot microfiltration technology designed to maximize clot retention NeVa & NeVa NET are CE-approved; not currently available in the U.S. #NeVa #Neurointervention #AIS #Stroke #LVO #Thrombectomy #FirstPassSuccess #NeVaFirstPass

?? The Vesalio team is happy to be at #WFITN2024 enjoying the forums, discussions and interactions with colleagues and partners! ??????’?? ???????? ???????? ??????????! If you're attending, please contact Diane Demet Tangun, George Sydnor, or Steve Rybka. We'd love to meet up and share the latest Vesalio news regarding our neurovascular technologies, clinical activities and innovation. ?????????? ???????? ??????! ?? WED, OCT 9, 11:30am - 12:00pm ?? It's exciting to see our technology featured in Dr. Fernando Ezequiel Petra’s presentation: Prospective Trial in the Use of the NeVa Thrombectomy Device: 265 Patients. Argentinean Experience. #NeVa VS is FDA-approved for the treatment of cerebral vasospasm due to aSAH and is not CE marked for this indication. #NeVa is CE-approved and not currently available in the U.S. #Neurointervention #AIS #Stroke #LVO #Thrombectomy #DoTheDropZone #FirstPassSuccess #NeVaFirstPass #NeVaVS4Vasospasm

Thank you for sharing Andras Katona!

??More #NeVaVS4Vasospasm Success in Georgia! Dr. Arthur Grigorian of Wellstar Health System North Fulton Medical Center in Roswell, Georgia, has performed another successful NeVa VS case! PATIENT PRESENTATION ?? 46 y/o female 8 days post-admission for subarachnoid hemorrhage (post-aSAH) ?? Severe left ACA A1/A2 and left MCA-M1 spasm TREATMENT ?? Heparin was given prior to NeVa VS deployment ?? NeVa VS was deployed 2x in the ACA and 1x in the MCA ?? ACA: deployed, retrieved, redeployed: total 5 min deployment time ?? MCA: deployed, retrieved: total 2 min deployment time ?? No Verapamil or other medication used after NeVa VS OUTCOMES ??Immediate and sustained improvement in narrowing ??No further #vasospasm treatment was needed. Vasospasmed branches were restored to normal size.?? "Another successful vasospasm resolution with the NeVa VS. The patient continues improvement on TCD, her neuro-exam is stable, and so far, no further endovascular treatment needed..." - Dr. Arthur Grigorian Thanks to Dr. Grigorian for trusting NeVa VS and sharing his experience. We're also grateful the patient didn't need any more treatments! #NeVaVS is the first and only FDA-approved device for post-aSAH cerebral vasospasm treatment. Reach out to see how NeVa VS can enhance your approach to vasospasm: Bob Bushok, Laura Hamilton, George Sydnor, Ashley Monaco, MHI, Ken Dunaway, Kevin M. NeVa VS is FDA-approved for the treatment of cerebral vasospasm due to aSAH and is not CE-marked for this indication. #Neurointervention

?? FIRST PASS RECANALIZATION IN THE FIRST #NeVa CASE IN BOLIVIA We're proud to announce the?first NeVa #thrombectomy case in Bolivia, performed by Dr. JORGE EDUARDO BOTELLO MARIN, Santa Cruz de la Sierra. Thank you for trusting our technology and may it be the first of many successful thrombectomies, saving patient lives and neurological function! PRESENTATION LVO starting at the ophthalmic segment of the right ICA, continuing into the carotid bifurcation, right M1 and A1 ?? All segment entirely occluded. TREATMENT ? Thrombectomy using NeVa 4.5 x 29 mm ? Aspiration via 62-inch ID catheter for flow control FIRST-PASS SUCCESS Complete recanalization (TICI 2B) in the first pass Recanalization achieved within 36 min from groin puncture #NeVa ?? for achieving impressive #FirstPassSuccess on ALL clot types For more on NeVa, contact your local Vesalio rep NeVa is CE-approved and not currently available in the U.S.

When Complexity Requires Simplicity ?? #pVasc Thrombectomy System “pVasc securely captures clot in a single, simple to use device that is easy to set-up and deliver. I have had positive experience using it frontline, and like how it can be used in 6 mm arteries all the way down to 2 mm.” Dr Venkatesh Ramaiah MD, FACS, Chief Vascular and Endovascular Surgery HonorHealth, Scottsdale, Arizona. To learn more about pVasc, please contact Bob Bushok. pVasc is FDA cleared for the removal of thrombi and emboli from peripheral vasculature and is not CE marked for this indication. #DoTheDropZone #PeripheralThrombectomy #AcuteLimbIschemia #VascularSurgery #PAD #CLTI

?? First #NeVa case in Kosovo! Thanks to Dr Naser Gjonbalaj and team for trusting our technology and sharing their story! ?? Here’s to many more NeVa successes in Kosovo! #DoTheDropZone #thrombectomy #stroke

?? CACI Webinar Alert: OUR NIGHTMARE – Thrombus in Cardiovascular Intervention ?? Join #CACI , UniFarma S.A., Vesalio team and top experts at this engaging session on thrombus management, featuring enVast?, the first coronary thrombus retriever! ?? Date: October 3rd, 2024 ?? Time: 18:00 (ART) ?? Language: Spanish ?? Open to all with prior registration! ?? Register here:?https://lnkd.in/evnaEf5E ?? What to Expect: ?? Introduction to #enVast by Antonio de los Santos from Vesalio ???? Expert insights from Dr. Dario Bongiovanni, MD, PhD ?? Argentina’s first case presented by Dr. Ignacio Seropian ?? Panel discussion with Drs. Ignacio Cigalini , Silvia Garbugino, Ezequiel Petra, Martín Rabellino, and Pablo Spaletra ?? Closing remarks by Dr. Juan José Fernández More info: https://www.caci.org.ar #Cardiology #Thrombectomy #CACIWebinar #Cardiovascular #DoTheDropZone

?? We’re thrilled to be participating in #BRAIN2024, happening in London, December 2-4, 2024! This event offers a fantastic platform for us to engage with global experts and discuss the latest advancements in neuroscience and stroke treatment. As we prepare for this year’s congress, we’re excited to share how #NeVa continues to support physicians in addressing #thrombectomy challenges, with remarkable outcomes like the 75% first-pass effect from the Royal London team’s #NeVa ONE Registry. For a look back at a former BRAIN discussion, Dr. Paul Bhogal’s presentation can be viewed here: https://lnkd.in/gcsUyB8V. We look forward to sharing more updates and insights at #BRAIN2024! Hope to see you there! NeVa & NeVa NET are CE-approved; not currently available in the U.S. Delta Surgical Diane Demet Tangun BRAIN Conference #AIS #Stroke #LVO #FirstPassSuccess #NeVaFirstPass